Characteristics and therapeutic approaches for patients diagnosed with T-ALL/LBL exhibiting t(8;14)(q24;q11)/TCRA/D:MYC translocation.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xian,Zhang

第一单位： Hebei Yanda Lu Daopei Hospital, Langfang, P.R. China.;Beijing Lu Daopei Institute of Hematology, Beijing, P.R. China.

作者： Xian,Zhang ^[1] ; Tong,Wang ^[1] ; Yang,Zhang ^[2] ; Fang,Wang ^[2] ; Jiaqi,Chen ^[2] ; Jingbo,Ni ^[2] ; Ruijuan,Sun ^[1] ; Zhijie,Wei ^[1] ; Gailing,Zhang ^[2] ; Wenqian,Li ^[2] ; Jingjing,Li ^[1] ; Peihua,Lu ^[1]

作者单位： Hebei Yanda Lu Daopei Hospital, Langfang, P.R. China.;Beijing Lu Daopei Institute of Hematology, Beijing, P.R. China. ^[1] Hebei Yanda Lu Daopei Hospital, Langfang, P.R. China. ^[2]

关键词 T-all/lbl TCRA/D::MYC translocation cd7 car-t t(8;14)(q24;q11) translocation

主题词人类(Humans);造血干细胞移植(Hematopoietic Stem Cell Transplantation);免疫疗法, 过继(Immunotherapy, Adoptive);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);前体T细胞淋巴母细胞白血病淋巴瘤(Precursor T-Cell Lymphoblastic Leukemia-Lymphoma);回顾性研究(Retrospective Studies);易位, 遗传(Translocation, Genetic)

DOI 10.1080/10428194.2023.2254428

PMID 37674391

发布时间 2024-07-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交